These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Glutamate and other CSF amino acids in Alzheimer's disease. Pomara N; Singh R; Deptula D; Chou JC; Schwartz MB; LeWitt PA Am J Psychiatry; 1992 Feb; 149(2):251-4. PubMed ID: 1734749 [TBL] [Abstract][Full Text] [Related]
25. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064 [TBL] [Abstract][Full Text] [Related]
26. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Nemes Z; Fésüs L; Egerházi A; Keszthelyi A; Degrell IM Neurobiol Aging; 2001; 22(3):403-6. PubMed ID: 11378245 [TBL] [Abstract][Full Text] [Related]
27. A preliminary study of free amino acids in the postmortem temporal cortex from Alzheimer-type dementia patients. Arai H; Kobayashi K; Ichimiya Y; Kosaka K; Iizuka R Neurobiol Aging; 1984; 5(4):319-21. PubMed ID: 6152305 [TBL] [Abstract][Full Text] [Related]
28. [The significance of cerebral white matter lesions in vascular dementia--from psychiatric aspects]. Matsushita M; Kawasaki H; Wada Y; Otomo E Rinsho Shinkeigaku; 1990 Dec; 30(12):1351-3. PubMed ID: 2099881 [TBL] [Abstract][Full Text] [Related]
29. Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia. Wallin A; Blennow K; Rosengren LE Dementia; 1996; 7(5):267-72. PubMed ID: 8872418 [TBL] [Abstract][Full Text] [Related]
30. Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia. Tohgi H; Abe T; Hashiguchi K; Saheki M; Takahashi S Neurosci Lett; 1994 Aug; 177(1-2):139-42. PubMed ID: 7824166 [TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Parnetti L; Reboldi GP; Gallai V Neurology; 2000 Feb; 54(3):735-7. PubMed ID: 10680813 [TBL] [Abstract][Full Text] [Related]
32. Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia. Smesny S; Stein S; Willhardt I; Lasch J; Sauer H J Neural Transm (Vienna); 2008 Aug; 115(8):1173-9. PubMed ID: 18584113 [TBL] [Abstract][Full Text] [Related]
39. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Fisher G; Lorenzo N; Abe H; Fujita E; Frey WH; Emory C; Di Fiore MM; D' Aniello A Amino Acids; 1998; 15(3):263-9. PubMed ID: 9871505 [TBL] [Abstract][Full Text] [Related]
40. Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia. Tarkowski E; Ringqvist A; Blennow K; Wallin A; Wennmalm A Dement Geriatr Cogn Disord; 2000; 11(6):322-6. PubMed ID: 11044777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]